GlassScriptPhysician profile
Matthew John Miller
NPI 1093021305
$1,932.50
in general payments reported to CMS, 2019-2025
11 companies · $81.80 in 2025
The $81.80 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $991 · 2021: $25.01 · 2022: $539 · 2023: $24.08 · 2024: $44.38 · 2025: $81.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.26 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,033.85 | 2020-2024 | Invisalign |
| Straumann USA LLC | $496.15 | 2022 | |
| Dentsply LLC | $159.90 | 2019 | |
| Zimvie INC. | $56.91 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $36.40 | 2021-2025 | Arestin |
| Kulzer, LLC | $34.14 | 2019 | |
| Kerr Corporation | $33.41 | 2019 | |
| Philips North America LLC | $24.78 | 2022 | |
| Premier Dental Products Company | $24.08 | 2023 | Two Striper, Aeropro Cordless Handpiece |
| Dentsply Sirona INC | $19.38 | 2024 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Aytu Biopharma, INC. | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.